Ascomycin;Immunomyc...

Ascomycin;Immunomycin;FR-900520;FK520)/ supplier with competitive price in stock-Rechems

Ascomycin;Immunomycin;FR-900520;FK520)/ supplier with competitive price in stock-Rechems

Min.Order / FOB Price:Get Latest Price

0

Negotiable

  • Min.Order :0
  • Purity: 98%

Keywords

Ascomycin Immunomycin FR-900520

Quick Details

  • Appearance:
  • Application:Medicinal Chemistry 、 Biomedicine、 Pharmaceutical intermediate、 Chemistry experiment 、Biological experiments 、Chemical reagent、 For R&D use only.
  • PackAge:Bottle and bag according to customer
  • ProductionCapacity:
  • Storage:Stored in well-closed containers
  • Transportation:DHL,UPS,FEDEX EMS or as your request

Superiority:

1.Custom synthetic service could be provided and COA/HPLC/HNMR is available.
2.Professional synthesis laboratory and production base.
3.Strong synthesis team and service team.
4.Professional data management system.
5.We provide the professional test date and product information.
6.Rich shipping methods,ex. Fedex,DHL,TNT,BY SEA and BY AIR.
7. We can accept various payment methods,Paypal,T/T, etc.
8.Professional packaging can be according the customers’requirment.

Details:

Ascomycin(Immunomycin, FR-900520, FK520) is an ethyl analog of tacrolimus (FK506) with strong immunosuppressant properties.IC50 Value: 0.55 nM Target: in vitro: When we used either CD4+CD8+ thymocytes or peripheral T cells activated by phorbol ester and ionomycin, the cell surface induction of CD5 was also partially blocked by CsA, FK-520 and rapamycin .Ascomycinalso had a 3-fold lower immunosuppressive potency in a popliteal lymph node hyperplasia assay, resulting in an equivalent therapeutic index consistent with a common mechanistic dependence on calcineurin inhibition .in vivo: In 14-day studies, nephrotoxicity was not induced by continuous i.p.infusion of ascomycin at 10 mg/kg/day or daily oral administration (up to 50 mg/kg/day) in rats on a normal diet, nor by continuous i.v.infusion (up to 6 mg/kg/day) in rats on a low salt diet to enhance susceptibility .
Shanghai Rechem science Co., Ltd.
Rechemsis focus on R&D of new APIS, signal transduction inhibitors and pharmaceutical intermediates. We follow closely the industry trend, and the latest research achievements in life science area.
Rechems is located in the largest biomedical base in China--Shanghai and cooperatively established modern production base and laboratory in surrounding areas. We have built up a good relationship with many US / European / Japanese pharmaceutical companies to conduct chemical research and inventory trading in medicinal chemistry.
Rechems's mission is to serve pharmaceutical community by providing excellent services and high-quality products in a timely manner.
Rechems's vision is to be recognized by our clients as one of the best suppliers of chemical products for our superior quality, efficient and cost-effective services.
We insist the principle of "Quality first, customer foremost, best credit, be pioneering and creative", looking forward to establishing good business relationships with customers all over the world. Let's work together for bright future!

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View